Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...
The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
LONDON (Reuters) - Hundreds of women have become pregnant after a long-term contraceptive implant failed to be properly inserted, the government's drugs and medical devices watchdog said on Wednesday.
Brigham researchers looked at tweets from 2014 to 2019 about contraceptive methods and found that only a small fraction were authored by health professionals. Patients are quick to turn to social ...